using old semaglutide The Pros and Cons of for Weight Loss What Happens If You Use

Gastrointestinal side effects are more common when combining these drugs because both influence gut motility and appetite

The information in the graphic above was pulled from a New York Times review of the Mounjaro Phase III clinical trial information

In clinical trials, it has demonstrated significant weight loss effects, leading to its FDA approval for the following indication and usage: WEGOVY is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in: adult patients with an initial body mass index of 30 kg/m2 or greater or 27 kg/m2 or greater in the presence of at least one weight-related comorbid condition

Can I take berberine with metformin